NCT00302003View on ClinicalTrials.gov

Combination Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Lymphoma

PHASE3CompletedINTERVENTIONAL
Enrollment

287

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

March 31, 2012

Study Completion Date

June 30, 2019

Conditions
Childhood Favorable Prognosis Hodgkin LymphomaChildhood Lymphocyte Depletion Hodgkin LymphomaChildhood Mixed Cellularity Hodgkin LymphomaChildhood Nodular Sclerosis Hodgkin LymphomaStage I Childhood Hodgkin LymphomaStage II Childhood Hodgkin Lymphoma
Interventions
RADIATION

radiation therapy

Undergo radiation therapy

DRUG

doxorubicin hydrochloride

Given IV

DRUG

vincristine sulfate

Given IV

DRUG

prednisone

Given orally

DRUG

cyclophosphamide

Given IV

DRUG

ifosfamide

Given IV

DRUG

vinorelbine tartrate

Given IV

DRUG

dexamethasone

Given IV

DRUG

etoposide phosphate

Given IV

DRUG

cisplatin

Given IV

DRUG

cytarabine

Given IV

BIOLOGICAL

filgrastim

Given IV or subcutaneously

Trial Locations (1)

91006-3776

Children's Oncology Group, Arcadia

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Children's Oncology Group

NETWORK

NCT00302003 - Combination Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Lymphoma | Biotech Hunter | Biotech Hunter